tradingkey.logo

Monogram Technologies Inc

MGRM
6.000USD
0.000
Market hours ETQuotes delayed by 15 min
216.53MMarket Cap
LossP/E TTM

Monogram Technologies Inc

6.000
0.000
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Monogram Technologies Inc

Currency: USD Updated: 2025-10-07

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals.

Monogram Technologies Inc's Score

Industry at a Glance

Industry Ranking
112 / 206
Overall Ranking
260 / 4702
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
8.400
Target Price
+40.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Monogram Technologies Inc Highlights

StrengthsRisks
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 20.36.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.02M shares, increasing 1.72% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.00M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.44.

Financial Health

Currency: USD Updated: 2025-10-07

The company's current financial score is 6.68, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
6.68
Change
0

Financials

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

Operational Efficiency

Growth Potential

Shareholder Returns

Monogram Technologies Inc's Company Valuation

Currency: USD Updated: 2025-10-07

The company’s current valuation score is 7.16, which is lower than the Healthcare Equipment & Supplies industry's average of 7.17. Its current P/E ratio is 0.00, which is NaN% below the recent high of 0.00 and +Inf% above the recent low of -11.36.

Score

Industry at a Glance

Previous score
7.16
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 112/206
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-07

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.71. The average price target for Monogram Technologies Inc is 8.40, with a high of 10.80 and a low of 6.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-07

The company’s current price momentum score is 6.66, which is lower than the Healthcare Equipment & Supplies industry's average of 6.78.

Score

Industry at a Glance

Previous score
7.02
Change
-0.36

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.773
Neutral
RSI(14)
7.226
Oversold
STOCH(KDJ)(9,3,3)
30.128
Sell
ATR(14)
0.581
High Vlolatility
CCI(14)
-466.667
Oversold
Williams %R
100.000
Oversold
TRIX(12,20)
-0.149
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
4.788
Buy
MA10
5.346
Buy
MA20
5.569
Buy
MA50
5.552
Buy
MA100
4.491
Buy
MA200
3.572
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-07

The latest institutional shareholding proportion is 5.20%, representing a quarter-over-quarter decrease of 86.39%. The largest institutional shareholder is The Vanguard, holding a total of 1.00M shares, representing 2.47% of shares outstanding, with 32.66% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Zimmer Biomet Holdings, Inc.
9.75M
--
Icahn School of Medicine at Mount Sinai
2.36M
--
Pro-Dex Inc
2.21M
+20.99%
The Vanguard Group, Inc.
Star Investors
1.00M
+12.05%
Geode Capital Management, L.L.C.
243.38K
-0.01%
Buckingham Strategic Partners, LLC
213.68K
--
BlackRock Institutional Trust Company, N.A.
105.75K
+12.83%
State Street Investment Management (US)
78.00K
--
Susquehanna International Group, LLP
59.81K
+9.05%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-07

The company’s current risk assessment score is 2.15, which is lower than the Healthcare Equipment & Supplies industry's average of 4.59. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.15
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+100.00%
240-Day Volatility
--

Return

Best Daily Return
60 days
+78.42%
120 days
+78.42%
5 years
--
Worst Daily Return
60 days
-100.00%
120 days
-100.00%
5 years
--
Sharpe Ratio
60 days
-0.30
120 days
+0.04
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+100.00%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-1.00
3 years
--
5 years
--
Skewness
240 days
-1.58
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
--
5 years
--
Standardised True Range
240 days
--
5 years
--
Downside Risk-Adjusted Return
120 days
+3.06%
240 days
+3.06%
Maximum Daily Upside Volatility
60 days
+207.99%
Maximum Daily Downside Volatility
60 days
+202.94%

Liquidity

Average Turnover Rate
60 days
+1.05%
120 days
+1.52%
5 years
--
Turnover Deviation
20 days
-44.24%
60 days
+62.79%
120 days
+136.04%

Peer Comparison

Healthcare Equipment & Supplies
Monogram Technologies Inc
Monogram Technologies Inc
MGRM
6.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI